Tevogen Bio announces partnership with BioCentriq, New Jersey Innovation Institute’s pioneering cell and gene therapy center, to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment. Under the partnership, experts from both entities will collaborate at BioCentriq’s state-of-the art GMP facilities to produce Tevogen’s proprietary COVID-19 targeted T cells. The teams will utilize the processes and technology required to ensure that all quality standards are met in the large scale manufacturing of Tevogen’s clinical grade, allogeneic T-cell therapy.

If you have ever checked a product to see if it is low emission, energy efficient or sustainably sourced, you may be looking at information that has been derived from life cycle inventory (LCI) records in any of several curated national public or proprietary databases.

Here you will find a weekly listing of updates and announcements for members of the NJIT campus community. Announcements are to be submitted through the form found at https://forms.gle/V6PBxUy5b3jkErMc8. Those submitted by each Thursday will be included in the following week's Updates and Announcements email.

NJIT men's volleyball won its ninth straight match of the season with a 3-0 (25-23, 25-18, 25-18) victory at Sacred Heart Saturday evening in EIVA Conference men's volleyball action. No. 11 NJIT recorded its third straight 3-0 sweep, won its ninth straight match, improved to 11-3 overall and 11-1 in the EIVA. The 11-3 start for the Highlanders is the best start since 2007 when the Highlanders started off the season 10-4.

The NJIT men's tennis team improved its season-opening win streak to three on Sunday, defeating host Bucknell 5-2 at the Central Pennsylvania Tennis Center. The Highlanders are 3-0 on the season, while the Bison dropped to 1-2. "It was great to pick up our first road win," explained Head Coach Ira Miller. "We took the momentum with the doubles point and closed out nicely in four of the six singles matches."

Selling information technology is a skill, but understanding its value in the buyer’s organization is a real differentiator. Both are core to a new graduate certificate program at New Jersey Institute of Technology.

High-tech hip and knee implants that not only return immobile people to walking, but to the tennis court. 3D printed models of patients’ anatomy that allow physicians to plan and practice complex operations in advance. Novel peptide-based hydrogels, also bioprinted, that are injected, self-reassemble in tissue spaces and deliver drugs and other small cargo over days and months. Looking ahead, but perhaps not too far, fully functional, human-scale tissues and organs that are capable of replacing failed organs.

Business leader, entrepreneur, and minor league baseball team owner Steven B. Kalafer HON ’20 and his wife Suzanne have made a million dollar gift to endow a scholarship that will support students throughout their pursuit of an undergraduate degree at the university. The new Kalafer Family Scholarship will pay tuition, room and board, and associated fees for high-achieving student-athletes who have demonstrated financial need.

NJIT's class of 2020 substantially found full-time employment despite the COVID-19 pandemic, with 95% either starting a full-time job or pursuing further education and other opportunities, newly released data from the university's Career Development Services indicates.

Sanchoy Das is a professor of mechanical and industrial engineering at NJIT who specializes in supply-chain and logistics engineering. This op-ed originally appeared in the Opinion Contributor section of Business Insider.